Press Releases

• April 20, 2021

IconOVir Bio Announces Formation of Scientific Advisory Board

• January 5, 2021

IconOVir Bio Raises $77 Million in Series A Financing to Develop Next-Generation Oncolytic Viruses to Treat Solid Tumors